Arrow Electronics
ARW
$222.95
+1.50%
Arrow Electronics, Inc. is a global distributor of electronic components and enterprise computing solutions, supplying semiconductors, passive and electromechanical components, and IT infrastructure — including servers, storage, software, and cloud services — to industrial and commercial customers across more than 80 countries. With roughly $46 billion in annualized revenue and over 22,000 employees, Arrow operates as one of the two dominant broadline distributors alongside Avnet, positioning it as a critical intermediary between thousands of component suppliers and tens of thousands of OEM, EMS, and value-added reseller customers. The current investor narrative centers on a sharp cyclical recovery in the Global Components segment, where quarterly revenue has reaccelerated to roughly 32% year-over-year growth on the back of AI infrastructure, data center, and industrial demand, driving earnings power well above prior-cycle levels. That recovery has powered a roughly 73% one-year share price gain and pushed the stock to fresh 52-week highs in early October, but the debate has now shifted to sustainability — whether the demand surge is a durable structural upcycle or a cyclical peak, and whether the market's re-rating from a low-single-digit earnings multiple to a high-single-digit one is justified.…
ARW
Arrow Electronics
$222.95
Related headlines
Investment Opinion: Should I buy ARW Today?
Rating: Hold. The core thesis is that Arrow Electronics is a deeply cyclical distributor benefiting from a powerful but potentially peaking demand upcycle, and while valuation is undemanding at 8.77x forward earnings, the risk/reward is balanced after a 73% one-year rally. The analyst average target of $235 implies 12% upside, but the low target of $200 suggests limited downside support, and the lack of a consensus recommendation (only 4 analysts) warrants caution. Supporting evidence includes revenue growth of 31.8% YoY, EPS growth of 46.5%, operating margin expansion to 3.78%, and TTM free cash flow of $899M. The forward P/E of 8.77x is well below the market average, and P/B of 0.87 is near book value. However, gross margin of 11.2% is thin, and P/CF of 89.1 indicates cash flow is not keeping pace with earnings. The biggest risks are a cyclical downturn that could cut EPS estimates of $27.20, margin compression from competitive pricing, and high beta (1.17) amplifying market volatility. The rating would upgrade to Buy if the stock pulls back to the $180-190 range (forward P/E ~7x) or if revenue growth accelerates above 35% with margin expansion. It would downgrade to Sell if revenue growth decelerates below 15% or if gross margin falls below 10.5%. Relative to its own history, the stock is no longer cheap on a P/E basis but still trades at a discount to the broader market; it appears fairly valued to slightly undervalued given growth prospects.
Sign up to view all
ARW 12-Month Price Forecast
The stock is at an inflection point: the cyclical recovery is well underway, but the easy money has been made after a 73% rally. Valuation is undemanding at 8.77x forward earnings, but this is offset by thin margins and the risk of a downturn. Analyst targets suggest modest upside to $235, but the low target of $200 and recent price weakness (-7.5% in 1 month) indicate caution. I would upgrade to bullish if the stock pulls back to $180-190 or if revenue growth accelerates with margin expansion. I would downgrade to bearish if revenue growth decelerates below 15% or if gross margin falls below 10.5%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Arrow Electronics's 12-month outlook, with a consensus price target around $235.00 and implied upside of +5.4% versus the current price.
Average Target
$235.00
0 analysts
Implied Upside
+5.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$200 - $250
Analyst target range
Bulls vs Bears: ARW Investment Factors
The bull case is currently stronger, driven by explosive revenue growth (31.8% YoY), margin expansion, and a deeply discounted forward P/E of 8.77x. However, the bear case highlights the risk of a cyclical peak after a 73% rally, razor-thin margins, and a high beta that could amplify losses. The most important tension is whether the AI-driven demand surge is structural or temporary; if it proves durable, the stock could re-rate further, but if it fades, earnings estimates of $27.20 may be at risk. Near-term momentum has weakened, with a 7.5% decline in the past month, suggesting investors are taking profits. Overall, the evidence leans bullish, but caution is warranted given the cyclical nature of the business.
Bullish
- Explosive revenue reacceleration: Q2 FY2026 revenue of $9.99B grew 31.8% YoY, up from $7.58B in Q2 FY2025, marking a sharp cyclical recovery. This is the strongest growth in the dataset and signals robust demand across Global Components.
- Earnings power inflecting sharply: Diluted EPS jumped to $5.26 in Q2 FY2026 from $3.59 a year ago, a 46.5% increase, while net income rose 45.3% to $272.7M. Operating margin expanded to 3.78% from 2.51% YoY, demonstrating operating leverage.
- Deep value on forward earnings: Forward P/E is only 8.77x and trailing P/E 9.99x, with PEG of 0.20 and P/B of 0.87. The market is pricing ARW at a steep discount to the broader market despite 73% one-year price appreciation.
- Strong free cash flow and balance sheet: TTM free cash flow is $899M, and debt-to-equity is a manageable 0.47 with a current ratio of 1.36. This provides flexibility for buybacks (share count fell from 53.3M to 51.3M YoY) and potential acquisitions.
Bearish
- Razor-thin margins limit error tolerance: Gross margin is only 11.2% and operating margin 3.0%, leaving little buffer for cost inflation or pricing pressure. Net margin is just 1.85%, so a small revenue miss or margin squeeze could disproportionately hit earnings.
- Cyclical peak risk after 73% run: The stock has surged 73.2% in one year and 85.6% YTD, hitting a 52-week high of $249.43. Recent news questions whether it's time to take profits, and the 1-month return is -7.5%, underperforming the S&P 500 by 6.5 percentage points.
- Valuation re-rating may be stretched: P/B of 0.87 still looks cheap, but P/CF is 89.1, indicating cash flow generation is lagging earnings. The forward P/E of 8.77x is based on estimated EPS of $27.20, which may be optimistic if the cycle turns.
- High beta amplifies downside: Beta of 1.17 means ARW is more volatile than the market. In a downturn, the stock could fall harder, as evidenced by the 18.7% max drawdown in the past 180 days.
ARW Technical Analysis
Beta
1.17
1.17x market volatility
Max Drawdown
-18.7%
Largest decline past year
52-Week Range
$102-$249
Price range past year
Annual Return
+88.5%
Cumulative gain past year
| Period | ARW Return | S&P 500 |
|---|---|---|
| 1m | -3.3% | +0.9% |
| 3m | +4.7% | +4.1% |
| 6m | +20.8% | +7.2% |
| 1y | +88.5% | +12.4% |
| ytd | +97.2% | +13.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ARW Fundamental Analysis
Quarterly Revenue
$10.0B
2026-07
Revenue YoY Growth
+31.8%
YoY Comparison
Gross Margin
11.3%
Latest Quarter
Free Cash Flow
$899337000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ARW Overvalued?
PE
10.0x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 4x~21x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
7.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are moderate but notable. Gross margin of 11.2% and operating margin of 3.0% leave little room for error; a 1% increase in cost of goods sold would wipe out roughly a third of operating income. The company relies on continued revenue growth to justify its valuation, as net margin is only 1.85%. However, debt-to-equity of 0.47 and current ratio of 1.36 indicate a healthy balance sheet, and TTM free cash flow of $899M provides a cushion. The main financial risk is a sharp reversal in demand that could lead to inventory write-downs and margin compression. Market and competitive risks include valuation compression if growth slows. While forward P/E of 8.77x is low, it is based on aggressive EPS estimates of $27.20; if estimates are cut, the stock could de-rate. Beta of 1.17 means ARW is more volatile than the market, and the 18.7% max drawdown in the past 180 days shows susceptibility to sharp declines. Competition from Avnet and other distributors is intense, and pricing pressure could erode margins. Recent news suggests the stock may be due for a pullback after a 119% run, and the 1-month relative strength of -6.5% versus the S&P 500 indicates waning momentum. The worst-case scenario would be a cyclical downturn combined with inventory corrections, leading to earnings misses and multiple compression. The 52-week low is $101.79, which is 51.5% below the current price of $209.76. If the stock were to retest that low, investors could lose over half their investment. Even a moderate decline to the analyst low target of $200 would represent a 4.7% loss, but a more severe scenario could see the stock fall to $150, a 28.5% decline, if growth stalls and estimates are cut.
FAQ
The key risks are: 1) Cyclical downturn risk – revenue growth of 31.8% YoY may not be sustainable, and a decline could lead to earnings misses and multiple compression. 2) Margin risk – gross margin of 11.2% is thin, and any cost pressure or pricing competition could significantly impact profitability. 3) Valuation risk – P/CF of 89.1 is elevated, and if cash flow does not improve, the stock could de-rate. 4) Market risk – beta of 1.17 means the stock is more volatile than the market, and the 18.7% max drawdown in the past 180 days shows susceptibility to sharp declines. These risks are ranked from most to least severe.
The 12-month forecast has three scenarios: Bull (30% probability) targeting $250-270, Base (50%) targeting $220-240, and Bear (20%) targeting $150-180. The base case is most likely, assuming revenue growth decelerates to 10-15% and EPS meets the $27.20 estimate, leading to a price around the analyst average of $235. The bull case requires sustained AI-driven demand and margin expansion, while the bear case assumes a cyclical downturn and estimate cuts. Key assumptions include stable gross margins above 11% and no major recession.
ARW appears undervalued on most metrics: forward P/E of 8.77x, trailing P/E of 9.99x, P/B of 0.87, and PEG of 0.20. These are well below the broader market and suggest the market is pricing in a cyclical peak. However, P/CF of 89.1 is high, indicating cash flow is not keeping pace with earnings, which may be a red flag. Relative to its own history, the stock has re-rated from a low-single-digit P/E to high-single-digit, but it still trades at a discount to peers like Avnet. The valuation implies the market expects earnings to decline or stagnate; if growth continues, the stock could re-rate higher. Overall, it is fairly valued to slightly undervalued given the growth outlook.
ARW is a good buy for value-oriented investors willing to accept cyclical risk, but current levels are not a screaming bargain after a 73% rally. The forward P/E of 8.77x and P/B of 0.87 suggest the stock is cheap relative to its earnings power, and the analyst average target of $235 implies 12% upside. However, the low target of $200 and the recent 7.5% one-month decline indicate near-term headwinds. The biggest downside risk is a cyclical downturn that could cut EPS estimates and compress the multiple. For long-term investors, accumulating on dips toward $180-190 would offer a better risk/reward. For short-term traders, the high beta (1.17) and momentum reversal suggest caution.
ARW is more suitable for medium-term investment (1-3 years) rather than short-term trading or long-term holding. The stock is in a cyclical upcycle, and the next 12-18 months will likely see the peak and subsequent deceleration. Its high beta (1.17) and lack of dividend make it less attractive for income-focused long-term investors. Short-term traders may find opportunities due to volatility, but timing the cycle is difficult. A suggested minimum holding period is 1-2 years to capture the current upcycle, with a plan to reassess as growth slows.